Life insurance for Alzheimers

Life insurance is available for people who have Alzheimer’s. Guaranteed-issue. NO health questions. Rates start at $18.35/month. Call today (877) 341-5377.

So, you’ve been told that your loved one doesn’t qualify for life insurance because he or she has Alzheimer’s. Our agency provides affordable life insurance coverage for our clients with Alzheimer’s. And it couldn’t be easier to qualify because the application has NO health questions.

This plan guarantees anyone aged 40 to 80 the opportunity to purchase up to $25,000 of permanent whole life protection by simply applying for coverage. No medical information or exam is required. The death benefit in the first two years is limited to 110% of the premiums paid. The policy pays 100% in the third year and thereafter. The full face amount of the policy is payable in all years in case of accidental death.

Features

  • NO medical or physical exam – NO health questions
  • Premiums will never increase
  • If your premiums are paid, the policy can never be cancelled.
  • Policy builds cash value

Rates

Alzheimer's life insurance rates for ages 40-80

 

* Rates are current as of October, 2014, and subject to change without notice. This page and illustrations provided are for summary purposes only and contain a general outline of coverages provided. This is not a contract or policy. For a complete and detailed description of coverages and exclusions, refer to the policy forms. Rates are paid monthly by EFT from a checking account on the same day each month or by credit card.

For more information, please send an
email to Dave MacDonald or call us:
Toll-free: (877) 341-5377
Local: (260) 422-5377

Our agency is presently licensed to write this Alzheimer’s Life Insurance plan in the States of Indiana, Ohio and Michigan.

For residents of Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Idaho, Illinois, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, North Carolina, North Dakota, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming – We will be adding other states in the near future. Click here to inquire when your state may be added. Life insurance agents interested in offering this product in their state may contact Dave MacDonald at (877) 341-5377 for more information.

See also: Seguro de vida para la enfermedad de Alzheimer

Call us today: (260) 422-5377 or
(877) 341-5377 (toll-free)

Dementia News — ScienceDaily

Read the latest medical research on dementia. Causes, symptoms, lowering the risks, care, medications and new treatments for dementia.
Experts criticize 'inaccurate' view that B Vitamins have no role in Alzheimer's disease prevention
Wednesday February 25th, 2015 01:27:39 PM

Patients in the very early stages of dementia could miss out on a potentially effective treatment after misleading research was published last year, say medical experts.
Skin test may shed new light on Alzheimer's and Parkinson's diseases
Tuesday February 24th, 2015 09:49:09 PM

Scientists have discovered a skin test that may shed new light on Alzheimer’s and Parkinson’s diseases. The study showed that skin biopsies can be used to detect elevated levels of abnormal proteins found in the two diseases.
Diabetes, depression predict dementia risk in people with slowing minds
Friday February 20th, 2015 06:33:35 PM

People with mild cognitive impairment are at higher risk of developing dementia if they have diabetes or psychiatric symptoms such as depression, finds a new review. Mild cognitive impairment is a state between normal aging and dementia, where someone's mind is functioning less well than would be expected for their age.
Tau-associated MAPT gene increases risk for Alzheimer's disease
Tuesday February 17th, 2015 06:11:20 PM

The microtubule-associated protein tau (MAPT) gene has been identified as increasing the risk for developing Alzheimer’s disease (AD), scientists report. The MAPT gene encodes the tau protein, which is involved with a number of neurodegenerative disorders, including Parkinson’s disease and AD. These findings provide novel insight into Alzheimer’s neurodegeneration, possibly opening the door for improved clinical diagnosis and treatment.
Tool can help assess cognitive impairment in multicultural populations
Tuesday February 17th, 2015 05:26:58 PM

The ability to assess cognitive impairment in multicultural older populations will become more important as demographics change worldwide. A new study reports that the Rowland Universal Dementia Assessment Scale is particularly effective in multicultural populations where English is not a patient's first language.
Amyloid formation may link Alzheimer disease and type 2 diabetes
Tuesday February 17th, 2015 01:37:41 PM

The pathological process amyloidosis, in which misfolded proteins (amyloids) form insoluble fibril deposits, occurs in many diseases, including Alzheimer disease (AD) and type 2 diabetes mellitus (T2D). However, little is known about whether different forms of amyloid proteins interact or how amyloid formation begins in vivo. A new study has found evidence that amyloid from the brain can stimulate the growth of fibrils in the murine pancreas and pancreatic-related amyloid can be found along with brain-related amyloid in human brain senile plaques.
Promising results for new Alzheimer's therapy
Friday February 13th, 2015 01:15:21 PM

Scientists have evaluated a new Alzheimer’s therapy in which the patients receive an implant that stimulates the growth of a certain type of nerve cell. The results suggest that the introduction of a nerve growth factor can prevent neuronal degradation in Alzheimer’s patients.